로딩 중…
지수 로딩 중…
SELLAS Life Sciences Group, Inc.
SLS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$8.05+3.74%
2026-06-18
Price Chart
SELLAS Life Sciences Group, Inc.+412.74%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.50B |
| Revenue | $0.00 |
| Net Income | $-29M |
| Total Assets | $114M |
| Net Assets | $107M |
| Value | |
| P/B | 13.94x |
| FCF Yield | -1.88% |
| Profitability | |
| ROE | -27.42% |
| ROA | -25.80% |
| Financial Health | |
| Debt Ratio | 6.30% |
| Total Debt | $871000.00 |
| FCF | $-28M |
| Cash | $107M |
| Current Ratio | 17.22x |
| Performance | |
| 1Y Return | 412.74% |
| 1M Return | 6.06% |
| From 52W High | -15.35% |
| 1Y MDD | -36.53% |
| Trading | |
| Volume | 11,053,113 shares |
| Trading Value | $90M |
| Per Share | |
| EPS | $-0.18 |
| BPS | $0.46 |